An analysis contracted by WellDoc found that the company’s digital therapeutic for Type 2 diabetes management could lead to an average savings of more than $250 per patient per month.
from MobiHealthNews http://ift.tt/2F2Ig0A
January 05, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Inside Apple's integration with Medisafe, the first test of the Apple Health Records APIYesterday’s announcement that Apple would open the API for Health Records in iOS 12 will likely spawn a whole host of integrations with digital health companies in the coming months. But one company has the distinction of bei… Read More
Pharma enthusiastic for digital medicine, but some roadblocks remainStakeholders across healthcare are beginning to weigh the benefits and challenges digital therapeutics could bring to their businesses, and pharma is no exception. During an afternoon roundtable session held yesterday at BIO … Read More
Athenahealth CEO Jonathan Bush leaves, board says it will consider sale or mergerAthenahealth announced Wednesday morning that founder and CEO Jonathan Bush is leaving the company and that the board will consider “strategic alternatives.” Those include hiring a new chief executive officer as well as a “sa… Read More
iBeat announces funding, partnership deals with insurersSan Francisco-based wearable tech company iBeat has announced new funding for its wearable continuous monitor, called Heart Watch. The investment comes from the life insurer funds SCOR Life & Health Ventures and Transamer… Read More
Israeli imaging AI startup Zebra Medical Vision secures $30M backingKibbutz Shefayim Israel-based deep learning startup Zebra Medical Vision has just closed a $30 million Series C funding round led by aMoon & Aurum Ventures with participation from Johnson & Johnson Innovation JJDC and… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment